1 enrolling by invitation. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Enrolling by invitation 1 |
Follow CellCept: new trials by email Literature Review of CellCept trials Research Report on CellCept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer Everolimus, Tacrolimus, Myfortic - Carcinoma, Hepatocellular | Phase 4 | Enrolling by invitation | Baylor Research Institute | 336 | 2014-03-01 | 2026-01-27 |
United States (1)